These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5845495)

  • 41. [BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
    BOZHINOV S
    Suvr Med (Sofiia); 1955; 6(7):96-100. PubMed ID: 13299060
    [No Abstract]   [Full Text] [Related]  

  • 42. [Biochemistry of hepatolenticular degeneration; its treatment with BAL].
    BONDUELLE M; HARL JM
    Bull Med; 1953 Jun; 67(12):333-5. PubMed ID: 13082329
    [No Abstract]   [Full Text] [Related]  

  • 43. [Case of hepatolenticular degeneration treated by BAL].
    DRABKOWSKA AM
    Neurol Neurochir Psychiatr Pol; 1956; 6(5):541-7. PubMed ID: 13407808
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study.
    STREIFLER M; FELDMAN S
    AMA Arch Neurol Psychiatry; 1953 Jan; 69(1):84-90. PubMed ID: 12996137
    [No Abstract]   [Full Text] [Related]  

  • 45. Ceruloplasmin, a link between copper and iron metabolism.
    Frieden E
    Ortop Travmatol Protez; 1969 Sep; 30(9):87-91. PubMed ID: 4910296
    [No Abstract]   [Full Text] [Related]  

  • 46. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
    BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
    Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
    [No Abstract]   [Full Text] [Related]  

  • 47. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 48. HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
    HERRING VG; KLATSKIN G; BRANDT IK
    J Pediatr; 1963 Oct; 63():550-60. PubMed ID: 14074413
    [No Abstract]   [Full Text] [Related]  

  • 49. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 50. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 51. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
    Chromý K
    Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
    BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
    Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes in Kayser-Fleischer ring during treatment of hepatolenticular degeneration.
    Mitchell AM; Heller GL
    Arch Ophthalmol; 1968 Nov; 80(5):622-31. PubMed ID: 5684310
    [No Abstract]   [Full Text] [Related]  

  • 54. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
    Lange J
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
    [No Abstract]   [Full Text] [Related]  

  • 55. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

  • 57. BILIARY EXCRETION FOF CAERULOPLASMIN COPPER.
    AISEN P; MORELL AG; ALPERT S; STERNLIEB I
    Nature; 1964 Aug; 203():873-4. PubMed ID: 14204078
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasilets IM; Shavlovskii MM
    Mol Biol; 1971; 5(6):739-42. PubMed ID: 5005463
    [No Abstract]   [Full Text] [Related]  

  • 59. WILSON'S DISEASE, AN INBORN ERROR OF METABOLISM AND A MODEL OF DEGENERATIVE CENTRAL NERVOUS SYSTEM DISEASE.
    RAVIN HA
    Bull Sinai Hosp Detroit; 1964; 12():25-30. PubMed ID: 14156393
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-invasive quantitation of corneal copper in hepatolenticular degeneration (Wilson's disease).
    Belkin M; Zeimer R; Chajek T; Friedman G; Melamed E
    Lancet; 1976 Feb; 1(7956):391-2. PubMed ID: 55651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.